Drug intelligence / Profile preview

allogeneic hematopoietic stem cells (Leipzig University)

Development stage
Unknown
Lead developer
Universität Leipzig
Modality
Stem Cell Therapies → Cell Therapies
Administration
Intravenous
01

Overview

Allogeneic hematopoietic stem cells are multipotent cells used in transplantation to treat various hematologic malignancies, including acute myeloid leukemia (AML). In the specific protocol developed by the University of Leipzig and the East German Study Group for Hematology and Oncology (OSHO), these cells are administered to elderly patients (aged 60-75) following a reduced-intensity conditioning (RIC) regimen. The RIC typically consists of fludarabine and low-dose total body irradiation (TBI). The primary therapeutic mechanism is the graft-versus-leukemia (GvL) effect, where donor-derived immune cells recognize and destroy residual leukemic cells in the recipient, complemented by the restoration of normal hematopoiesis.

Other names
human stem cellsallogeneic stem cell transplantationallo-HSCThematopoietic stem cells

Beyond the preview

Go deeper on allogeneic hematopoietic stem cells (Leipzig University).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on allogeneic hematopoietic stem cells (Leipzig University).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call